Skip to main content
Vijay Sankaran, MD, Pediatric Hematology & Oncology, Boston, MA

Vijay Ganesh Sankaran MD PhD


Attending Physician in Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Lodish Family Chair, Boston Children's Hospital; Jan Ellen Paradise, MD Associate Professor of Pediatrics, Harvard Medical School

Join to View Full Profile
  • 300 Longwood AvenueBoston, MA 02115

  • Phone+1 617-355-6000

Dr. Sankaran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Vijay Sankaran is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Beth Israel Deaconess Hospital. He received his medical degree from Harvard Medical School and has been in practice 12 years. He is experienced in pediatric hematology/oncology, including in thalassemia, sickle cell disease, bone marrow failure syndromes, genetic predisposition to blood cancers, and other disorders impacting hematopoiesis.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2015
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
  • Harvard Medical School
    Harvard Medical SchoolClass of 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Novel Genomic Screening Tool Enables Precision Reverse-Engineering of Genetic Programming in Cells
    Novel Genomic Screening Tool Enables Precision Reverse-Engineering of Genetic Programming in CellsApril 4th, 2025
  • Genomic Tool Enables Precise Genetic Engineering
    Genomic Tool Enables Precise Genetic EngineeringApril 3rd, 2025
  • Episode 1: The First CRISPR Medicine for Sickle Cell Disease
    Episode 1: The First CRISPR Medicine for Sickle Cell DiseaseFebruary 20th, 2025
  • Join now to see all

Grant Support

  • Variant to Function Mapping of B-ALL Risk LociBOSTON CHILDREN'S HOSPITAL2024–2029
  • Systematic Genetic Dissection of Human ErythropoiesisBOSTON CHILDREN'S HOSPITAL2014–2029
  • Selective pressures from inherited variation impacting myeloproliferative neoplasm initiationBOSTON CHILDREN'S HOSPITAL2022–2027
  • Clonal analysis of cancer by mitochondrial DNA barcodingBRIGHAM AND WOMEN'S HOSPITAL2023–2026
  • Hemoglobin Switching MeetingBOSTON CHILDREN'S HOSPITAL2024–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: